US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Nektar Says Eli Lilly Botched Autoimmune Drug Trials

By Ayden Crosby · August 7, 2023, 7:47 PM EDT

Nektar Therapeutics is accusing Eli Lilly of butchering and delaying clinical trials for a new autoimmune-disease drug the two companies agreed to develop together, claiming the pharma giant ruined the drug's...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Nektar Therapeutics v. Eli Lilly & Co

Case Number

3:23-cv-03943

Court

California Northern

Nature of Suit

Contract: Other

Date Filed

August 07, 2023

Featured Stories

Courts Rule On DOJ Trans Care Subpoena, Abortion And More No Photo Available

Gianna Ferrarin

Law360 Healthcare Authority looks at a split Ninth Circuit decision backing the U.S. Department of Justice's administrative subpoena o... (more story)

Iowa Board Opens Door For Doctor Self-Defense Arguments No Photo Available

Mark Payne

An Iowa medical board's decision to dismiss disciplinary charges against a doctor who claimed the state's "stand your ground" law enab... (more story)

Lilly's Obesity Drug Suits Signal New Reality For GLP-1 Giants No Photo Available

Yeji Jesse Lee

Obesity-drug makers haven’t been shy about suing players encroaching on their turf. But a new round of lawsuits from Eli Lilly may sig... (more story)